Utah Medical Products, Inc. (UTMD)
NASDAQ: UTMD · Real-Time Price · USD
72.23
+1.19 (1.68%)
At close: Nov 6, 2026, 4:00 PM EST
71.99
-0.24 (-0.33%)
After-hours: Nov 6, 2026, 7:43 PM EST

Utah Medical Products Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
229179208306365365
Market Cap Growth
23.36%-14.01%-31.80%-16.18%-0.11%18.97%
Enterprise Value
14495120218296301
Last Close Price
72.2355.2059.3679.8894.0992.37

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
21.6315.8915.0318.3822.1424.69
Forward PE
-17.8017.8017.8017.8017.80
PS Ratio
6.574.655.106.096.987.44
PB Ratio
1.861.501.782.383.193.41
P/TBV Ratio
2.181.722.072.794.034.85
P/FCF Ratio
20.0312.5214.2814.1217.9317.68
P/OCF Ratio
19.3612.2014.0613.7217.2517.22
PEG Ratio
-1.191.191.191.191.19

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
4.132.472.944.345.656.14
EV/EBITDA Ratio
10.786.066.499.4311.0211.51
EV/EBIT Ratio
12.067.477.6512.9814.9315.95
EV/FCF Ratio
12.616.658.2410.0614.5314.58

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.000.000.000.000.000.00
Debt / EBITDA Ratio
0.010.020.020.010.010.02
Debt / FCF Ratio
-0.020.020.010.020.02
Net Debt / Equity Ratio
-0.69-0.72-0.70-0.72-0.65-0.56
Net Debt / EBITDA Ratio
-6.35-5.44-4.46-4.01-2.79-2.32
Net Debt / FCF Ratio
--5.97-5.66-4.28-3.67-2.93
Asset Turnover
0.280.310.320.390.440.43
Inventory Turnover
1.581.971.822.192.612.83
Quick Ratio
18.8134.3623.1820.4413.5217.65
Current Ratio
21.2337.6225.6422.5615.0919.54
Return on Equity (ROE)
8.81%9.54%11.29%13.72%14.88%14.09%
Return on Assets (ROA)
5.97%6.51%7.62%8.09%10.33%10.38%
Return on Invested Capital (ROIC)
26.90%29.78%36.87%36.91%36.65%29.85%
Return on Capital Employed (ROCE)
9.70%10.60%13.20%12.80%16.80%16.90%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
4.62%6.30%6.65%5.44%4.52%4.05%
FCF Yield
4.99%7.99%7.00%7.08%5.58%5.66%
Dividend Yield
1.74%2.18%1.93%1.41%1.16%0.86%
Payout Ratio
37.74%35.29%30.70%25.74%19.20%77.53%
Buyback Yield / Dilution
3.07%7.51%3.68%0.17%0.46%0.33%
Total Shareholder Return
4.82%9.69%5.61%1.57%1.62%1.18%
SEC Filings: 10-K · 10-Q